Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Tripp

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Archives of Physical Medicine and Rehabilitation|May 20, 2021
Characterizing the Experience of Spasticity after Spinal Cord Injury: A National Survey Project of the Spinal Cord Injury Model Systems CentersEdelle C Field-Fote, Catherine L Furbish, Natalie E Tripp, et al.
Annals of Surgery|June 1, 1997
Effect of repair strategy on hospital cost for infants with tetralogy of FallotR M Ungerleider, R J Kanter, M O'Laughlin, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Conversion of human-selective PPARalpha agonists to human/mouse dual agonists: a molecular modeling analysisMinmin Wang, Leonard L Winneroski, Robert J Ardecky, et al.
Journal of Medicinal Chemistry|April 30, 2004
Design and synthesis of alpha-aryloxy-alpha-methylhydrocinnamic acids: a novel class of dual peroxisome proliferator-activated receptor alpha/gamma agonistsYanping Xu, Christopher J Rito, Garret J Etgen, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2016
Novel bicyclo[3.1.0]hexane analogs as antagonists of metabotropic glutamate 2/3 receptors for the treatment of depressionBruce A Dressman, Eric G Tromiczak, Mark D Chappell, et al.
Journal of Medicinal Chemistry|December 23, 2016
Discovery of (1S,2R,3S,4S,5R,6R)-2-Amino-3-[(3,4-difluorophenyl)sulfanylmethyl]-4-hydroxy-bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Hydrochloride (LY3020371·HCl): A Potent, Metabotropic Glutamate 2/3 Receptor Antagonist with Antidepressant-Like ActivityMark D Chappell, Renhua Li, Stephon C Smith, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Archives of Physical Medicine and Rehabilitation|May 20, 2021
Characterizing the Experience of Spasticity after Spinal Cord Injury: A National Survey Project of the Spinal Cord Injury Model Systems CentersEdelle C Field-Fote, Catherine L Furbish, Natalie E Tripp, et al.
Annals of Surgery|June 1, 1997
Effect of repair strategy on hospital cost for infants with tetralogy of FallotR M Ungerleider, R J Kanter, M O'Laughlin, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Conversion of human-selective PPARalpha agonists to human/mouse dual agonists: a molecular modeling analysisMinmin Wang, Leonard L Winneroski, Robert J Ardecky, et al.
Journal of Medicinal Chemistry|April 30, 2004
Design and synthesis of alpha-aryloxy-alpha-methylhydrocinnamic acids: a novel class of dual peroxisome proliferator-activated receptor alpha/gamma agonistsYanping Xu, Christopher J Rito, Garret J Etgen, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2016
Novel bicyclo[3.1.0]hexane analogs as antagonists of metabotropic glutamate 2/3 receptors for the treatment of depressionBruce A Dressman, Eric G Tromiczak, Mark D Chappell, et al.
Journal of Medicinal Chemistry|December 23, 2016
Discovery of (1S,2R,3S,4S,5R,6R)-2-Amino-3-[(3,4-difluorophenyl)sulfanylmethyl]-4-hydroxy-bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Hydrochloride (LY3020371·HCl): A Potent, Metabotropic Glutamate 2/3 Receptor Antagonist with Antidepressant-Like ActivityMark D Chappell, Renhua Li, Stephon C Smith, et al.
Pageof 3